Extracorporeal membrane oxygenatin and extracorporeal albumin dialysis in pediatric patients with sepsis and multi-organ dysfunction syndrome

R. Tiruvoipati, T. Moorthy, S. K. Balasubramanian, V. Platt, Giles J. Peek

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Extracorporeal membrane oxygenation (ECMO) is used in managing patients with potentially reversible cardio-respiratory failure refractory to conventional methods. Multiorgan dysfunction syndrome (MODS), usually due to sepsis, remains the main cause of mortality in such patients. We report a series of six pediatric patients with sepsis-induced MODS where extracorporeal albumin dialysis (EAD) was used while the patients were on ECMO. The age of the patients ranged between 1 month and 17 years. The mean pediatric index of mortality (PIM) score at admission was 67.5%. All these patients further deteriorated with MODS and EAD was used as rescue therapy. At institution of EAD, 4 patients had dysfunction of 4 organs and 2 patients had dysfunction of 5 organs. The number of EAD cycles ranged between 1 and 3. Three out of the 6 patients (50%) survived to discharge from the intensive care unit and two of the six patients (33%) survived to hospital discharge. According to our previous experience and published results, all these patients would have been expected to die. The present results suggest that EAD may prove to have a role in the treatment of pediatric patients with sepsis-induced MODS. Further research is required to identify the group of patients who would benefit most by EAD as well as understand the clearance of inflammatory mediators and other mechanisms involved with the use of EAD.

Original languageEnglish (US)
Pages (from-to)227-234
Number of pages8
JournalInternational Journal of Artificial Organs
Volume30
Issue number3
StatePublished - Mar 2007
Externally publishedYes

Fingerprint

Pediatrics
Dialysis
Renal Dialysis
Albumins
Sepsis
Membranes
Oxygenation
Extracorporeal Membrane Oxygenation
Intensive care units
Refractory materials
Mortality
Respiratory Insufficiency
Intensive Care Units

Keywords

  • Extracorporeal albumin dialysis
  • Extracorporeal membrane oxygenation
  • Molecular adsorbent re-circulating system
  • Multiorgan dysfunction syndrome
  • Sepsis

ASJC Scopus subject areas

  • Biophysics

Cite this

Extracorporeal membrane oxygenatin and extracorporeal albumin dialysis in pediatric patients with sepsis and multi-organ dysfunction syndrome. / Tiruvoipati, R.; Moorthy, T.; Balasubramanian, S. K.; Platt, V.; Peek, Giles J.

In: International Journal of Artificial Organs, Vol. 30, No. 3, 03.2007, p. 227-234.

Research output: Contribution to journalArticle

Tiruvoipati, R. ; Moorthy, T. ; Balasubramanian, S. K. ; Platt, V. ; Peek, Giles J. / Extracorporeal membrane oxygenatin and extracorporeal albumin dialysis in pediatric patients with sepsis and multi-organ dysfunction syndrome. In: International Journal of Artificial Organs. 2007 ; Vol. 30, No. 3. pp. 227-234.
@article{2f492c3fa57749938d34ae6dbac2fe8e,
title = "Extracorporeal membrane oxygenatin and extracorporeal albumin dialysis in pediatric patients with sepsis and multi-organ dysfunction syndrome",
abstract = "Extracorporeal membrane oxygenation (ECMO) is used in managing patients with potentially reversible cardio-respiratory failure refractory to conventional methods. Multiorgan dysfunction syndrome (MODS), usually due to sepsis, remains the main cause of mortality in such patients. We report a series of six pediatric patients with sepsis-induced MODS where extracorporeal albumin dialysis (EAD) was used while the patients were on ECMO. The age of the patients ranged between 1 month and 17 years. The mean pediatric index of mortality (PIM) score at admission was 67.5{\%}. All these patients further deteriorated with MODS and EAD was used as rescue therapy. At institution of EAD, 4 patients had dysfunction of 4 organs and 2 patients had dysfunction of 5 organs. The number of EAD cycles ranged between 1 and 3. Three out of the 6 patients (50{\%}) survived to discharge from the intensive care unit and two of the six patients (33{\%}) survived to hospital discharge. According to our previous experience and published results, all these patients would have been expected to die. The present results suggest that EAD may prove to have a role in the treatment of pediatric patients with sepsis-induced MODS. Further research is required to identify the group of patients who would benefit most by EAD as well as understand the clearance of inflammatory mediators and other mechanisms involved with the use of EAD.",
keywords = "Extracorporeal albumin dialysis, Extracorporeal membrane oxygenation, Molecular adsorbent re-circulating system, Multiorgan dysfunction syndrome, Sepsis",
author = "R. Tiruvoipati and T. Moorthy and Balasubramanian, {S. K.} and V. Platt and Peek, {Giles J.}",
year = "2007",
month = "3",
language = "English (US)",
volume = "30",
pages = "227--234",
journal = "International Journal of Artificial Organs",
issn = "0391-3988",
publisher = "Wichtig Publishing",
number = "3",

}

TY - JOUR

T1 - Extracorporeal membrane oxygenatin and extracorporeal albumin dialysis in pediatric patients with sepsis and multi-organ dysfunction syndrome

AU - Tiruvoipati, R.

AU - Moorthy, T.

AU - Balasubramanian, S. K.

AU - Platt, V.

AU - Peek, Giles J.

PY - 2007/3

Y1 - 2007/3

N2 - Extracorporeal membrane oxygenation (ECMO) is used in managing patients with potentially reversible cardio-respiratory failure refractory to conventional methods. Multiorgan dysfunction syndrome (MODS), usually due to sepsis, remains the main cause of mortality in such patients. We report a series of six pediatric patients with sepsis-induced MODS where extracorporeal albumin dialysis (EAD) was used while the patients were on ECMO. The age of the patients ranged between 1 month and 17 years. The mean pediatric index of mortality (PIM) score at admission was 67.5%. All these patients further deteriorated with MODS and EAD was used as rescue therapy. At institution of EAD, 4 patients had dysfunction of 4 organs and 2 patients had dysfunction of 5 organs. The number of EAD cycles ranged between 1 and 3. Three out of the 6 patients (50%) survived to discharge from the intensive care unit and two of the six patients (33%) survived to hospital discharge. According to our previous experience and published results, all these patients would have been expected to die. The present results suggest that EAD may prove to have a role in the treatment of pediatric patients with sepsis-induced MODS. Further research is required to identify the group of patients who would benefit most by EAD as well as understand the clearance of inflammatory mediators and other mechanisms involved with the use of EAD.

AB - Extracorporeal membrane oxygenation (ECMO) is used in managing patients with potentially reversible cardio-respiratory failure refractory to conventional methods. Multiorgan dysfunction syndrome (MODS), usually due to sepsis, remains the main cause of mortality in such patients. We report a series of six pediatric patients with sepsis-induced MODS where extracorporeal albumin dialysis (EAD) was used while the patients were on ECMO. The age of the patients ranged between 1 month and 17 years. The mean pediatric index of mortality (PIM) score at admission was 67.5%. All these patients further deteriorated with MODS and EAD was used as rescue therapy. At institution of EAD, 4 patients had dysfunction of 4 organs and 2 patients had dysfunction of 5 organs. The number of EAD cycles ranged between 1 and 3. Three out of the 6 patients (50%) survived to discharge from the intensive care unit and two of the six patients (33%) survived to hospital discharge. According to our previous experience and published results, all these patients would have been expected to die. The present results suggest that EAD may prove to have a role in the treatment of pediatric patients with sepsis-induced MODS. Further research is required to identify the group of patients who would benefit most by EAD as well as understand the clearance of inflammatory mediators and other mechanisms involved with the use of EAD.

KW - Extracorporeal albumin dialysis

KW - Extracorporeal membrane oxygenation

KW - Molecular adsorbent re-circulating system

KW - Multiorgan dysfunction syndrome

KW - Sepsis

UR - http://www.scopus.com/inward/record.url?scp=34248361629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248361629&partnerID=8YFLogxK

M3 - Article

C2 - 17417762

AN - SCOPUS:34248361629

VL - 30

SP - 227

EP - 234

JO - International Journal of Artificial Organs

JF - International Journal of Artificial Organs

SN - 0391-3988

IS - 3

ER -